SNYNF:OTCMKTS
Sanofi SA
78,55 US$
0,00%
(0,00) 1D
15 tet, 12:34:26 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për SNYNF...
Kapitalizimi i tregut
98,00 mld
Vëllimi mesatar
5,39 mijë
Vëllimi
117,00
Maksimumi 52-javor
106,34 US$
Minimumi 52-javor
76,76 US$
Beta
0,32
Aksionet në qarkullim
1,21 mld
Numri i punonjësve
75 mijë
Kapitalizimi i tregut
98,00 mld
Vëllimi mesatar
5,39 mijë
Vëllimi
117,00
Maksimumi 52-javor
106,34 US$
Minimumi 52-javor
76,76 US$
Beta
0,32
Aksionet në qarkullim
1,21 mld
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
10 orë më parë
Sanofi expands antibody alliance: what it means for Sanofi stock
Simply Wall Street
·
1 ditë më parë
AI Drug Candidate Might Change The Case For Investing In Sanofi (ENXTPA:SAN)
Utah Business
·
1 ditë më parë
Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate
Stocktwits
·
2 ditë më parë
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today?
Profili
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Rreth Sanofi SA
Drejtori ekzekutivPaul Hudson | Belén Garijo
Punonjësit74,8 mijë
Themeluar më1973
SeliaParisi, Île-de-France, Francë
Sektori-
Uebsajtisanofi.com